Workboat Indexes
Articles published by Panbela Therapeutics, Inc.
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Acceptance of Eflornithine (DFMO) Abstract for Oral Presentation at Digestive Disease Week
April 30, 2024
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Therapeutics Announces Interim Data Analysis for ASPIRE Trial Pushed to Q1 2025
April 22, 2024
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela to Host Fourth Quarter and Year End 2023 Earnings Conference Call on March 26, 2024
March 12, 2024
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Regains Compliance with Nasdaq Listing Standards for Bid Price and Publicly Held Shares Requirements
February 15, 2024
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Announces Closing of Approximately $9.0 Million Public Offering
February 01, 2024
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Therapeutics Announces US WorldMeds NDA Approval for Eflornithine (DFMO) in Pediatric Neuroblastoma
December 18, 2023
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Acceptance of Polyamine Inhibitor CAR-T Combination Abstract for Online Publication
October 25, 2023
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Announces Issuance of New Patent in China for Claims of a Novel Process for the Production of SBP-101
September 26, 2023
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela to Present at the LD Micro Investor Conference
September 19, 2023
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Panbela Announces Issuance of New Patent in Chile for Claims of a Novel Process for the Production of Flynpovi
September 05, 2023
Via GlobeNewswire
Tickers
PBLA
![](https://ml.globenewswire.com/media/31cebafa-5ebb-4b5c-a749-9c2f662a6b4a/small/image001-jpg.jpg)
Via GlobeNewswire
Tickers
PBLA
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.